Gene · 2813
NIH grants1,628
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,628
Download this page as JSON| Grant | Title | GP2 papers | Newest fiscal year |
|---|---|---|---|
| K99AI156012 | Viral factors responsible for Lassa virus pathogenicity | 1 | 2022 |
| OT2OD025337 | Research Matters: Creating Possibilities to Achieve Health and Wellness for All of Us Research Program | 1 | 2022 |
| OT2OD026550 | Trans-America Consortium of the Health Care Systems Research Network for the All of Us Research Program | 1 | 2022 |
| R00ES029104 | Neurovascular Consequences of Inhaled Uranium Mine-Site Dust Exposure | 1 | 2022 |
| R01AA021510 | Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis | 1 | 2022 |
| R01AG027002 | Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults | 1 | 2022 |
| R01AG062217 | Geroscience approaches to mitigate tauopathy in aged mouse brain | 1 | 2022 |
| R01AI134293 | Identification of drug-targetable IFN-stimulated genes mediating immune activation during ART-treated HIV-1 infection | 1 | 2022 |
| R01AI137344 | Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis | 1 | 2022 |
| R01CA117907 | Mechanisms of gene expression control in the p53 network | 1 | 2022 |
| R01CA155169 | Understanding Resistance to Next Generation Antiandrogens | 1 | 2022 |
| R01CA173636 | Role of TET2 mutations in malignant transformation and acute myeloid leukemia | 1 | 2022 |
| R01CA222227 | Immunomodulating Ruthenium Metal Complexes for Melanoma PhotodynamicTherapy | 1 | 2022 |
| R01DK072614 | Membrane communication: the foundation of renal epithelial structure | 1 | 2022 |
| R01DK095004 | The role of the ErbB4 and ErbB3 neuregulin receptors in intestinal epithelial regeneration | 1 | 2022 |
| R01DK115477 | Notch-mediated 5ARI resistance in human BPH | 1 | 2022 |
| R01DK117001 | Diversity Supplement to R01 Mitochondrial Dysfunction and Mitophagy in Ileitis | 1 | 2022 |
| R01DK118154 | Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohn’s Disease | 1 | 2022 |
| R01DK118568 | Modulation of the Intestinal Immune Response in Necrotizing Enterocolitis | 1 | 2022 |
| R01DK120559 | Quantitative Ultrasound Imaging Biomarkers of Crohn's Disease | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2813/grants?page=23